ArticleNature cancer2025
Atezolizumab plus personalized neoantigen vaccination in urothelial cancer: a phase 1 trial.
Mansi Saxena et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleNature cancer2025
Mansi Saxena et al.PubMed ↗Publisher ↗
No numbers read from the abstract.